ORAL IMMUNIZATION WITH SALMONELLA-TYPHI TY21A-BASED CLONES EXPRESSING VIBRIO-CHOLERAE O-ANTIGEN - SERUM BACTERICIDAL ANTIBODY-RESPONSES IN MAN IN RELATION TO PREIMMUNIZATION ANTIBODY-LEVELS

被引:7
作者
ATTRIDGE, S
机构
[1] Enterovax Ltd, Department of Microbiology and Immunology, The University of Adelaide, Adelaide, SA 5001
关键词
SALMONELLA-TYPHI TY21A; VIBRIO-CHOLERAE; O-ANTIGEN; PREIMMUNIZATION ANTIBODY LEVELS; BACTERICIDAL RESPONSE;
D O I
10.1016/0264-410X(91)90007-S
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous studies have shown that oral immunization with Salmonella typhi Ty21a-based clones expressing Vibrio cholerae O-antigen elicits serum antibody responses against the foreign polysaccharide in human volunteers. These responses are conveniently assayed by complement-dependent bacteriolysis of V. cholerae. In this report the bactericidal responses generated by two such clones are analysed in relation to the pre-immunization titres of various serum antibodies. A significant association was found, in that recipients with higher prevaccine titres of anti-V. cholerae bactericidal antibodies were less likely to register significant bactericidal responses following immunization. These results are discussed in relation to the concept of vaccine exclusion.
引用
收藏
页码:877 / 882
页数:6
相关论文
共 15 条
  • [1] PROPHYLACTIC SIGNIFICANCE OF THE NONLIPOPOLYSACCHARIDE ANTIGENS OF VIBRIO-CHOLERAE
    ATTRIDGE, SR
    ROWLEY, D
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (05) : 931 - 939
  • [2] CHARACTERIZATION AND IMMUNOGENICITY OF EX880, A SALMONELLA-TYPHI TY21A-BASED CLONE WHICH PRODUCES VIBRIO-CHOLERAE O-ANTIGEN
    ATTRIDGE, SR
    DEARLOVE, C
    BEYER, L
    VANDENBOSCH, L
    HOWLES, A
    HACKETT, J
    MORONA, R
    LABROOY, J
    ROWLEY, D
    [J]. INFECTION AND IMMUNITY, 1991, 59 (07) : 2279 - 2284
  • [3] BERGMANN KC, 1988, REV INFECT DIS, V10, P939
  • [4] SERUM ANTIBODIES TO LIPOPOLYSACCHARIDE AND NATURAL IMMUNITY TO SHIGELLOSIS IN AN ISRAELI MILITARY POPULATION
    COHEN, D
    GREEN, MS
    BLOCK, C
    ROUACH, T
    OFEK, I
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (05) : 1068 - 1071
  • [5] DIXON WJ, 1990, BMDP STATISTICAL SOF, V2
  • [6] FORREST BD, 1988, LANCET, V1, P81
  • [7] EVALUATION OF A UDP-GLUCOSE-4-EPIMERASELESS MUTANT OF SALMONELLA-TYPHI AS A LIVE ORAL VACCINE
    GILMAN, RH
    HORNICK, RB
    WOODWARD, WE
    DUPONT, HL
    SNYDER, MJ
    LEVINE, MM
    LIBONATI, JP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1977, 136 (06) : 717 - 723
  • [8] A GALE-VIA (VI-ANTIGEN-NEGATIVE) MUTANT OF SALMONELLA-TYPHI TY2 RETAINS VIRULENCE IN HUMANS
    HONE, DM
    ATTRIDGE, SR
    FORREST, B
    MORONA, R
    DANIELS, D
    LABROOY, JT
    BARTHOLOMEUSZ, RCA
    SHEARMAN, DJC
    HACKETT, J
    [J]. INFECTION AND IMMUNITY, 1988, 56 (05) : 1326 - 1333
  • [9] LEVINE MM, 1989, REV INFECT DIS, V11, pS552
  • [10] THE COMMON MUCOSAL IMMUNE-SYSTEM AND CURRENT STRATEGIES FOR INDUCTION OF IMMUNE-RESPONSES IN EXTERNAL SECRETIONS
    MESTECKY, J
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1987, 7 (04) : 265 - 276